Kate Guilfoyle

1.5k total citations
14 papers, 261 citations indexed

About

Kate Guilfoyle is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Kate Guilfoyle has authored 14 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 5 papers in Infectious Diseases and 5 papers in Immunology. Recurrent topics in Kate Guilfoyle's work include Influenza Virus Research Studies (12 papers), Respiratory viral infections research (9 papers) and Viral gastroenteritis research and epidemiology (4 papers). Kate Guilfoyle is often cited by papers focused on Influenza Virus Research Studies (12 papers), Respiratory viral infections research (9 papers) and Viral gastroenteritis research and epidemiology (4 papers). Kate Guilfoyle collaborates with scholars based in United Kingdom, Germany and Netherlands. Kate Guilfoyle's co-authors include Othmar G. Engelhardt, Ruth Harvey, James S. Robertson, Diane Major, Carolyn Nicolson, Rachel Johnson, Geert van Amerongen, Rishi D. Pathirana, Bart L. Haagmans and Lisa Allnoch and has published in prestigious journals such as Nature Communications, PLoS ONE and Journal of Virology.

In The Last Decade

Kate Guilfoyle

12 papers receiving 257 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kate Guilfoyle United Kingdom 11 159 105 63 61 24 14 261
Junyuan Ren United Kingdom 9 137 0.9× 127 1.2× 61 1.0× 84 1.4× 42 1.8× 10 285
Lou G. Boykins United States 9 213 1.3× 97 0.9× 177 2.8× 123 2.0× 17 0.7× 14 444
Janne Tynell Finland 11 137 0.9× 160 1.5× 127 2.0× 87 1.4× 8 0.3× 14 371
Parul Sharma United Kingdom 7 78 0.5× 75 0.7× 29 0.5× 43 0.7× 5 0.2× 13 193
Celia Cannon United Kingdom 14 299 1.9× 40 0.4× 116 1.8× 64 1.0× 37 1.5× 19 476
Inga Szurgot France 6 54 0.3× 96 0.9× 42 0.7× 66 1.1× 9 0.4× 7 180
Elias Harkins United States 5 41 0.3× 102 1.0× 34 0.5× 77 1.3× 5 0.2× 6 217
Ahyun Son South Korea 10 42 0.3× 73 0.7× 34 0.5× 178 2.9× 10 0.4× 17 286
Jordan J. Clark United Kingdom 9 54 0.3× 118 1.1× 46 0.7× 79 1.3× 4 0.2× 13 248
Rahul Basu United States 13 120 0.8× 200 1.9× 126 2.0× 101 1.7× 3 0.1× 24 456

Countries citing papers authored by Kate Guilfoyle

Since Specialization
Citations

This map shows the geographic impact of Kate Guilfoyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate Guilfoyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate Guilfoyle more than expected).

Fields of papers citing papers by Kate Guilfoyle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kate Guilfoyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate Guilfoyle. The network helps show where Kate Guilfoyle may publish in the future.

Co-authorship network of co-authors of Kate Guilfoyle

This figure shows the co-authorship network connecting the top 25 collaborators of Kate Guilfoyle. A scholar is included among the top collaborators of Kate Guilfoyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kate Guilfoyle. Kate Guilfoyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Guilfoyle, Kate, Leon de Waal, Geert van Amerongen, et al.. (2025). Highly Pathogenic Avian Influenza Virus A/H5N1 Subclade 2.3.4.4b Isolated from a European Grey Seal ( Halichoerus grypus ) Is Highly Virulent in Ferrets. The Journal of Infectious Diseases. 232(6). e886–e896. 1 indexed citations
3.
Armando, Federico, Georg Beythien, Franziska Kaiser, et al.. (2022). SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters. Nature Communications. 13(1). 3519–3519. 62 indexed citations
4.
McMillan, Christopher L. D., Stacey T. M. Cheung, Naphak Modhiran, et al.. (2021). Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses. npj Vaccines. 6(1). 135–135. 11 indexed citations
5.
Guilfoyle, Kate, Diane Major, Heather James, et al.. (2020). Protective efficacy of a polyvalent influenza A DNA vaccine against both homologous (H1N1pdm09) and heterologous (H5N1) challenge in the ferret model. Vaccine. 39(34). 4903–4913. 11 indexed citations
6.
Guilfoyle, Kate, Milan Ganguly, Parikshit Tyagi, et al.. (2020). Immunogenicity and efficacy comparison of MDCK cell-based and egg-based live attenuated influenza vaccines of H5 and H7 subtypes in ferrets. Vaccine. 38(40). 6280–6290. 8 indexed citations
7.
Dong, Wei, Inta Gribonika, Tjarko Meijerhof, et al.. (2019). Cross-Protective Potential and Protection-Relevant Immune Mechanisms of Whole Inactivated Influenza Virus Vaccines Are Determined by Adjuvants and Route of Immunization. Frontiers in Immunology. 10. 646–646. 17 indexed citations
8.
Dong, Wei, Tjarko Meijerhof, Kate Guilfoyle, et al.. (2018). Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines. Frontiers in Immunology. 9. 2312–2312. 27 indexed citations
9.
10.
Major, Diane, Jessica A. Chichester, Rishi D. Pathirana, et al.. (2015). Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge. Human Vaccines & Immunotherapeutics. 11(5). 0–0. 23 indexed citations
11.
Cox, Rebecca Jane, Diane Major, Gabriel Kristian Pedersen, et al.. (2015). Matrix M H5N1 Vaccine Induces Cross-H5 Clade Humoral Immune Responses in a Randomized Clinical Trial and Provides Protection from Highly Pathogenic Influenza Challenge in Ferrets. PLoS ONE. 10(7). e0131652–e0131652. 12 indexed citations
12.
Nicolson, Carolyn, Ruth Harvey, Rachel Johnson, et al.. (2011). An additional oligosaccharide moiety in the HA of a pandemic influenza H1N1 candidate vaccine virus confers increased antigen yield in eggs. Vaccine. 30(4). 745–751. 18 indexed citations
13.
Harvey, Ruth, et al.. (2011). Improved Antigen Yield in Pandemic H1N1 (2009) Candidate Vaccine Viruses with Chimeric Hemagglutinin Molecules. Journal of Virology. 85(12). 6086–6090. 24 indexed citations
14.
Harvey, Ruth, Carolyn Nicolson, Rachel Johnson, et al.. (2010). Improved haemagglutinin antigen content in H5N1 candidate vaccine viruses with chimeric haemagglutinin molecules. Vaccine. 28(50). 8008–8014. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junyuan Ren Breakdown of academic impact, for papers by Lou G. Boykins Breakdown of academic impact, for papers by Janne Tynell Breakdown of academic impact, for papers by Parul Sharma Breakdown of academic impact, for papers by Celia Cannon Breakdown of academic impact, for papers by Inga Szurgot Breakdown of academic impact, for papers by Elias Harkins Breakdown of academic impact, for papers by Ahyun Son Breakdown of academic impact, for papers by Jordan J. Clark Breakdown of academic impact, for papers by Rahul Basu
Rankless by CCL
2026